Literature DB >> 21277708

The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine.

Kelli R Rodvelt1, Clark E Oelrichs, Lucas R Blount, Kuo-Hsien Fan, Susan Z Lever, John R Lever, Dennis K Miller.   

Abstract

BACKGROUND: Methamphetamine's behavioral effects have been attributed to its interaction with monoamine transporters; however, methamphetamine also has affinity for sigma receptors.
METHOD: The present study investigated the effect of the sigma receptor agonist SA 4503 and the sigma receptor antagonists BD-1047 and BD-1063 on methamphetamine-evoked [(3)H]dopamine release from preloaded rat striatal slices. The effect of SA 4503 on methamphetamine-induced hyperactivity and on the discriminative stimulus properties of methamphetamine also was determined.
RESULTS: SA 4503 attenuated methamphetamine-evoked [(3)H]dopamine release in a concentration-dependent manner. BD-1047 and BD-1063 did not affect release. SA 4503 dose-dependently potentiated and attenuated methamphetamine-induced hyperactivity. SA 4503 pretreatment augmented the stimulus properties of methamphetamine.
CONCLUSIONS: Our findings indicate that SA 4503 both enhances and inhibits methamphetamine's effects and that sigma receptors are involved in the neurochemical, locomotor stimulatory and discriminative stimulus properties of methamphetamine.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277708      PMCID: PMC3105201          DOI: 10.1016/j.drugalcdep.2010.12.018

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  29 in total

1.  Effect of sigma ligands on the cocaine-induced convulsions in mice.

Authors:  G Skuza
Journal:  Pol J Pharmacol       Date:  1999 Nov-Dec

Review 2.  Role of endogenous acetylcholine in the control of the dopaminergic system via nicotinic receptors.

Authors:  Uwe Maskos
Journal:  J Neurochem       Date:  2010-05-04       Impact factor: 5.372

3.  The selective sigma(1) receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (-)-nicotine in rats.

Authors:  B Horan; E L Gardner; S L Dewey; J D Brodie; C R Ashby
Journal:  Eur J Pharmacol       Date:  2001-08-24       Impact factor: 4.432

4.  Effects of sigma(1) receptor agonist SA4503 and neuroactive steroids on performance in a radial arm maze task in rats.

Authors:  L B Zou; K Yamada; M Sasa; Y Nakata; T Nabeshima
Journal:  Neuropharmacology       Date:  2000-07-10       Impact factor: 5.250

5.  Lobeline inhibits nicotine-evoked [(3)H]dopamine overflow from rat striatal slices and nicotine-evoked (86)Rb(+) efflux from thalamic synaptosomes.

Authors:  D K Miller; P A Crooks; L P Dwoskin
Journal:  Neuropharmacology       Date:  2000-10       Impact factor: 5.250

6.  Inhibition by sigma receptor ligand, MS-377, of N-methyl- D-aspartate-induced currents in dopamine neurons of the rat ventral tegmental area.

Authors:  Yuu Yamazaki; Miwa Ishioka; Hiroaki Matsubayashi; Taku Amano; Masashi Sasa
Journal:  Psychopharmacology (Berl)       Date:  2002-02-27       Impact factor: 4.530

7.  Regulation of sigma-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering rats.

Authors:  Teruo Hayashi; Zuzana Justinova; Eri Hayashi; Gianfrancesco Cormaci; Tomohisa Mori; Shang-Yi Tsai; Chanel Barnes; Steven R Goldberg; Tsung-Ping Su
Journal:  J Pharmacol Exp Ther       Date:  2009-11-25       Impact factor: 4.030

8.  Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.

Authors:  Alfred Meurs; Ralph Clinckers; Guy Ebinger; Yvette Michotte; Ilse Smolders
Journal:  Eur J Neurosci       Date:  2007-11-14       Impact factor: 3.386

9.  Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studies.

Authors:  Rae R Matsumoto; Jamaluddin Shaikh; Lisa L Wilson; Shreedeepalakshmi Vedam; Andrew Coop
Journal:  Eur Neuropsychopharmacol       Date:  2008-08-27       Impact factor: 4.600

10.  Regulating ankyrin dynamics: Roles of sigma-1 receptors.

Authors:  T Hayashi; T P Su
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-09       Impact factor: 11.205

View more
  16 in total

Review 1.  The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

Authors:  Danielle O Sambo; Joseph J Lebowitz; Habibeh Khoshbouei
Journal:  Pharmacol Ther       Date:  2018-01-31       Impact factor: 12.310

2.  N-phenylpropyl-N'-substituted piperazines occupy sigma receptors and alter methamphetamine-induced hyperactivity in mice.

Authors:  Dennis K Miller; Eric S Park; Susan Z Lever; John R Lever
Journal:  Pharmacol Biochem Behav       Date:  2016-11-13       Impact factor: 3.533

3.  Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine.

Authors:  Michael J Seminerio; Matthew J Robson; Ahmed H Abdelazeem; Christophe Mesangeau; Seshulatha Jamalapuram; Bonnie A Avery; Christopher R McCurdy; Rae R Matsumoto
Journal:  AAPS J       Date:  2011-12-20       Impact factor: 4.009

4.  Lack of cocaine-like discriminative-stimulus effects of σ-receptor agonists in rats.

Authors:  Takato Hiranita; Paul L Soto; Gianluigi Tanda; Jonathan L Katz
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

5.  SA 4503 attenuates cocaine-induced hyperactivity and enhances methamphetamine substitution for a cocaine discriminative stimulus.

Authors:  Kelli R Rodvelt; Susan Z Lever; John R Lever; Lucas R Blount; Kuo-Hsien Fan; Dennis K Miller
Journal:  Pharmacol Biochem Behav       Date:  2010-11-27       Impact factor: 3.533

6.  Ether modifications to 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazine (SA4503): effects on binding affinity and selectivity for sigma receptors and monoamine transporters.

Authors:  Rong Xu; Sarah A Lord; Ryan M Peterson; Emily A Fergason-Cantrell; John R Lever; Susan Z Lever
Journal:  Bioorg Med Chem       Date:  2014-11-11       Impact factor: 3.641

7.  Ultra-performance liquid chromatography tandem mass spectrometry method for the determination of AZ66, a sigma receptor ligand, in rat plasma and its application to in vivo pharmacokinetics.

Authors:  Seshulatha Jamalapuram; Pradeep Kumar Vuppala; Ahmed H Abdelazeem; Christopher R McCurdy; Bonnie A Avery
Journal:  Biomed Chromatogr       Date:  2013-04-05       Impact factor: 1.902

8.  Synthesis and σ1 Receptor Binding of Halogenated N,N'-Diphenethylethylenediamines.

Authors:  Jonathan M Fitzsimmons; John R Lever; Susan Z Lever
Journal:  Med Chem (Los Angeles)       Date:  2011-12-25

Review 9.  Sigma Receptors and Substance Use Disorders.

Authors:  Valentina Sabino; Callum Hicks; Pietro Cottone
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 3.650

10.  A Role for Sigma Receptors in Stimulant Self Administration and Addiction.

Authors:  Jonathan L Katz; Tsung-Ping Su; Takato Hiranita; Teruo Hayashi; Gianluigi Tanda; Theresa Kopajtic; Shang-Yi Tsai
Journal:  Pharmaceuticals (Basel)       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.